Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHA:688179)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Jan 1, 2019	Jan 1, 2018	Jan 1, 2017
Research and Trials Development Industry	695.72M	533.56M	402.88M	378.10M	287.66M
Research and Trials Development Industry Growth	30.39%	32.44%	6.55%	31.44%	22.82%
Total	695.72M	533.56M	402.88M	378.10M	287.66M
Total Growth	30.39%	32.44%	6.55%	31.44%	22.82%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Jan 1, 2019	Jan 1, 2018	Jan 1, 2017
China	695.72M	533.56M	402.88M	378.10M	287.66M
China Growth	30.39%	32.44%	6.55%	31.44%	22.82%
Total	695.72M	533.56M	402.88M	378.10M	287.66M
Total Growth	30.39%	32.44%	6.55%	31.44%	22.82%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 5, 2026

Data Sources Report a data error